This is an old revision of this page, as edited by CatPath(talk | contribs) at 22:20, 25 January 2021(Undid revision 1002731166 by 95.148.23.185 (talk)Ref spam; study hasn't been peer reviewed). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 22:20, 25 January 2021 by CatPath(talk | contribs)(Undid revision 1002731166 by 95.148.23.185 (talk)Ref spam; study hasn't been peer reviewed)
Sentrin-specific protease 6 is an enzyme that in humans is encoded by the SENP6gene.[5]
Function
Ubiquitin-like molecules (UBLs), such as SUMO1, are structurally related to ubiquitin and can be ligated to target proteins in a similar manner as ubiquitin. However, covalent attachment of UBLs does not result in degradation of the modified proteins. SUMO1 modification is implicated in the targeting of RANGAP1 to the nuclear pore complex, as well as in stabilization of I-kappa-B-alpha (NFKBIA; MIM 164008) from degradation by the 26S proteasome. Like ubiquitin, UBLs are synthesized as precursor proteins, with 1 or more amino acids following the C-terminal glycine-glycine residues of the mature UBL protein. Thus, the tail sequences of the UBL precursors need to be removed by UBL-specific proteases, such as SENP6, prior to their conjugation to target proteins